In Nanotech Metrics, Safety Should Trump Size, Experts Say

29 Apr 2013

• By Dan Schiff

Presenters at the FDLI annual conference say evaluations of novel health care and consumer products based on nanotechnology should focus on safety and efficacy more than particle size. The Project on Emerging Nanotechnologies is updating its product inventory to include nanomaterial safety data.

The field of nanotechnology, in recent years a “next big thing” in health care and consumer products, may be too hung up on definitions and nomenclature when the safety and efficacy of the resulting novel products should take priority, stakeholders suggest.

The nonprofit Project on Emerging Nanotechnologies has internalized that notion and is working to upgrade its inventory of consumer products...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

US FDA’s Rising First-Cycle Complete Response Rate Draws Congress’ Attention

11 Jun 2025

• By Sue Sutter

The House Appropriations Committee wants an analysis of how issues that led to CRLs could have been resolved within the first review cycle and seeks an agency crackdown on counterfeit GLP-1 agonists.

‘Clean Sweep’ Of US CDC Vaccine Committee Puts Kennedy In Driver’s Seat

10 Jun 2025

• By Bridget Silverman

With a 25-27 June meeting looming, HHS Secretary Robert F. Kennedy Jr. can fill all 17 spots on the CDC's Advisory Committee on Immunization Practices with people he says will "exercise independent judgment."